Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study
Author(s) -
W. H. F. Sutherland,
Sylvia A. de Jong,
Rob Walker
Publication year - 2003
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfg484
Subject(s) - hypochlorous acid , paraoxonase , pon1 , arylesterase , chemistry , lipoprotein , taurine , hydrogen peroxide , biochemistry , aryldialkylphosphatase , medicine , endocrinology , enzyme , cholesterol , amino acid , genotype , gene
Serum paraoxonase 1 (PON1) is an oxidant-sensitive enzyme associated with high-density lipoprotein (HDL) that inhibits the atherogenic oxidation of low-density lipoprotein (LDL). In haemodialysis patients, production of reactive oxygen species, such as hypochlorous acid (HOCl) and hydrogen peroxide, is increased and serum PON1 arylesterase is abnormally low. We have examined the effect of HOCl and the uraemic milieu on serum PON1 arylesterase activity and the ability of HDL to inhibit LDL oxidation in vitro.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom